UBS Group’s OrthoPediatrics KIDS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $685K | Buy |
43,177
+2,804
| +7% | +$49K | ﹤0.01% | 5833 |
|
|
2025
Q4 | $717K | Sell |
40,373
-17,321
| -30% | -$303K | ﹤0.01% | 5845 |
|
|
2025
Q3 | $1.07M | Buy |
57,694
+22,677
| +65% | +$467K | ﹤0.01% | 5521 |
|
|
2025
Q2 | $752K | Sell |
35,017
-2,153
| -6% | -$46.5K | ﹤0.01% | 5684 |
|
|
2025
Q1 | $915K | Buy |
37,170
+7,563
| +26% | +$187K | ﹤0.01% | 5355 |
|
|
2024
Q4 | $686K | Buy |
29,607
+21,602
| +270% | +$540K | ﹤0.01% | 5621 |
|
|
2024
Q3 | $217K | Sell |
8,005
-3,094
| -28% | -$93.7K | ﹤0.01% | 5813 |
|
|
2024
Q2 | $319K | Sell |
11,099
-8,085
| -42% | -$248K | ﹤0.01% | 5343 |
|
|
2024
Q1 | $559K | Buy |
19,184
+5,930
| +45% | +$166K | ﹤0.01% | 5110 |
|
|
2023
Q4 | $431K | Buy |
13,254
+9,162
| +224% | +$266K | ﹤0.01% | 5217 |
|
|
2023
Q3 | $131K | Sell |
4,092
-8,597
| -68% | -$331K | ﹤0.01% | 5662 |
|
|
2023
Q2 | $556K | Buy |
12,689
+3,145
| +33% | +$145K | ﹤0.01% | 4733 |
|
|
2023
Q1 | $423K | Buy |
9,544
+2,549
| +36% | +$113K | ﹤0.01% | 4821 |
|
|
2022
Q4 | $278K | Buy |
6,995
+4,763
| +213% | +$198K | ﹤0.01% | 5190 |
|
|
2022
Q3 | $103K | Sell |
2,232
-117
| -5% | -$5.74K | ﹤0.01% | 5681 |
|
|
2022
Q2 | $101K | Buy |
2,349
+1,283
| +120% | +$58.7K | ﹤0.01% | 5426 |
|
|
2022
Q1 | $58K | Sell |
1,066
-3,658
| -77% | -$187K | ﹤0.01% | 6353 |
|
|
2021
Q4 | $283K | Buy |
4,724
+4,303
| +1,022% | +$268K | ﹤0.01% | 5415 |
|
|
2021
Q3 | $28K | Buy |
421
+217
| +106% | +$14.1K | ﹤0.01% | 6822 |
|
|
2021
Q2 | $13K | Sell |
204
-3,707
| -95% | -$213K | ﹤0.01% | 7787 |
|
|
2021
Q1 | $190K | Sell |
3,911
-2,382
| -38% | -$114K | ﹤0.01% | 5527 |
|
|
2020
Q4 | $259K | Buy |
6,293
+2,652
| +73% | +$122K | ﹤0.01% | 5074 |
|
|
2020
Q3 | $168K | Sell |
3,641
-521
| -13% | -$24.2K | ﹤0.01% | 4898 |
|
|
2020
Q2 | $182K | Sell |
4,162
-1,654
| -28% | -$74.4K | ﹤0.01% | 4869 |
|
|
2020
Q1 | $231K | Sell |
5,816
-5,934
| -51% | -$266K | ﹤0.01% | 4609 |
|
|
2019
Q4 | $552K | Buy |
11,750
+4,793
| +69% | +$186K | ﹤0.01% | 4753 |
|
|
2019
Q3 | $246K | Buy |
6,957
+5,047
| +264% | +$175K | ﹤0.01% | 5081 |
|
|
2019
Q2 | $75K | Buy |
1,910
+1,632
| +587% | +$65.8K | ﹤0.01% | 5595 |
|
|
2019
Q1 | $12K | Sell |
278
-2,955
| -91% | -$112K | ﹤0.01% | 6686 |
|
|
2018
Q4 | $112K | Buy |
3,233
+218
| +7% | +$6.91K | ﹤0.01% | 5443 |
|
|
2018
Q3 | $111K | Buy |
3,015
+2,057
| +215% | +$63K | ﹤0.01% | 5508 |
|
|
2018
Q2 | $26K | Buy |
958
+858
| +858% | +$18.3K | ﹤0.01% | 6506 |
|
|
2018
Q1 | $2K | Sell |
100
-188
| -65% | -$3.33K | ﹤0.01% | 7538 |
|
|
2017
Q4 | $6K | Buy |
+288
| New | +$5.51K | ﹤0.01% | 7305 |
|
Other funds holding KIDS
B
GIM
VCM
SCM
UBS Group's KIDS Position: Q1 2026 in Review
UBS Group increased its OrthoPediatrics (KIDS) stake by 6.9% in Q1 2026, buying an estimated $49K and bringing the position to 43,177 shares worth $685K. The position accounts for ﹤0.01% of the portfolio, ranked #5833.
UBS Group first reported a position in KIDS in Q4 2017 and has held it in 34 quarters since. The position peaked at $1.07M in Q3 2025. 121 funds tracked by Wall St. Rank hold KIDS as of Q1 2026.
- UBS Group held 43,177 shares of OrthoPediatrics worth $685K as of Q1 2026.
- UBS Group bought 2,804 OrthoPediatrics shares in Q1 2026, an estimated $49K.
- OrthoPediatrics made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5833 holding.
- UBS Group first reported a position in OrthoPediatrics in Q4 2017 and has held it in 34 quarters since.
- UBS Group's OrthoPediatrics position peaked at $1.07M in Q3 2025.
- 121 funds tracked by Wall St. Rank held OrthoPediatrics as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.